No Data
No Data
Piper Sandler Initiates Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Announces Target Price $38
Morgan Stanley Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Maintains Target Price $27
Morgan Stanley Remains a Buy on Centessa Pharmaceuticals (CNTA)
Express News | Centessa Pharmaceuticals PLC : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $38
Centessa Pharmaceuticals: Promising Orexin Pipeline and Strong Financials Drive Buy Rating
Centessa Pharmaceuticals Shares Are Trading Lower After the Company Reported Q4 Financial Results and Missed Its EPS Estimate.